Machine Learning

Thinkific reports strong 2025 revenue and a return to profitability, betting its future on enterprise clients and its new 'Thinker' AI platform.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

The data center giant raises major capital to double its capacity, targeting the explosive growth in AI and cloud computing. Here's what it means.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

As Hyperfine preps its 2025 results, investors and clinicians watch to see if its portable Swoop MRI can translate clinical promise into financial success.

With a strong cash position, ArriVent pushes its lead lung cancer drug toward a mid-2026 data readout while building a new pipeline in ADCs.

Luminys Systems Corp. unveils its Vertical Experience Center, shifting from generic products to tailored AI security solutions for retail and education.

Scientists find herpes melts the inside of our cells to replicate faster, a discovery that could revolutionize treatments for a host of viral diseases.

A new partnership integrates conversational AI with deep EHR analysis, promising to save doctors time, improve diagnoses, and boost hospital revenue.

New preclinical data shows Quanta Therapeutics' inhibitors remain potent against cancers that have developed resistance to advanced pan-RAS treatments.

On its 50th anniversary, NAHQ launches a new ecosystem to arm the healthcare workforce against staff shortages, financial pressures, and digital disruption.

Automotive SaaS firm MotorK posts a dramatic financial turnaround, achieving positive cash flow in H2 2025 by leveraging AI and a bold customer strategy.

Breker Verification Systems adds expert Larry Lapides, signaling a strategic push to solve the critical verification hurdle for the growing RISC-V ecosystem.

Lighthouse's new AI platform saves millions and finds key documents 40x faster, reshaping the high-stakes world of legal eDiscovery. But what does it mean?

With a new SVP of Global Sales, Slingshot Biosciences is poised to scale its synthetic cell mimic technology, targeting the booming cell therapy market.

A new report reveals a stark disconnect. While 41% of employers view AI as a team member, most employees are not convinced, creating a major workplace rift.

Amid a 400% surge in ransomware targeting SAP, Onapsis and partners like Microsoft will tackle the security crisis driven by AI and cloud adoption.

Sarah Sommer, a deaf digital marketing exec, joins the Oberkotter Foundation board, blending personal insight with corporate strategy to advance hearing healthcare.